Private equity-backed technology group ClearCourse has acquired Belfast-based Blue Zinc for an undisclosed sum.
ClearCourse is a leading group of innovative technology brands providing software solutions and an integrated payments platform.
Founded in 2002, Blue Zinc provides innovative solutions for the management of patient referrals, clinical pathways and clinics for the physical and mental health segments in the healthcare sector.
Following the deal, co-founders and current joint managing directors Kyle Lunn and Ronnie Johnston will continue with the company, overseeing Blue Zinc’s strategic direction.
The company will form part of ClearCourse’s Business Services division and expands the latter’s growing footprint in the healthcare space.
Blue Zinc’s flagship digital solutions are designed to cater to a customer base with specialist demands – up to 1,000 small- to medium-sized clinics deploy TM3, the company’s flagship clinic management product.
Blue Zinc’s Corporate solutions enable the delivery of a range of healthcare services through the efficient digital management of patient referrals, clinical pathways and treatments.
It provides an integrated digital platform for all stakeholders including funders, patients, case managers and clinics (including third party networks).
This year Blue Zinc launched its latest offering, Click, as the first clinic management solution designed specifically for the talking therapies market.
The business has been operating in Australia since 2006 and recently acquired Collab IT, a software company that distributed its product suite in the region.
The company’s integration with ClearCourse presents multiple benefits, including the opportunity to implement the proprietary payments platform ClearAccept.
Gerry Gualtieri, CEO of ClearCourse, said: “Healthcare is one of the country’s most crucial sectors, and one in which we stand to see the most significant material benefits from tailored software and technology.
“We are delighted to welcome a company that exhibits such clear dedication and potential for growth, as we look forward to supporting another brilliant British business that underpins the provision of vital care.”
Kyle Lunn, managing director of Blue Zinc, said: “Over the last 20 years, we are proud of becoming a valued and well-established provider of innovation across health technology, especially at a time when the demand for healthcare services is increasing exponentially.
“With ClearCourse’s support, we plan to scale and extend the services we provide to our existing clients, who play a vital role in the physical and mental wellbeing of patients worldwide, while bringing innovation to new areas of healthcare.”
Founded in 2018, ClearCourse is a group of innovative technology companies investing in industry-specific and market-leading software businesses which serve small and medium enterprises across the UK.”